CBC, Mubadala co-lead $315m investment in China’s Hasten Biopharma

CBC, Mubadala co-lead $315m investment in China’s Hasten Biopharma

Photographer: Jonathan Drake/Bloomberg News

Asian healthcare-focused investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala have co-led a $315 million investment in China’s Hasten Biopharma, according to a company announcement on Thursday.

Edited by: Pramod Mathew